Grunenthal sees core business sales grow 9% as EBITA leaps 147% – The Pharma Letter

This Week at Macy’s: 20-50% off select styles! Valid 9/8-9/27.

Grunenthal sees core business sales grow 9% as EBITA leaps 147%
The Pharma Letter
Additionally, development of the business in Brazil and other countries as well as favorable exchange rate developments in the Latin American business also contributed to revenue growth in the first half of 2012, Grunenthal noted. Enjoying this article?

and more »

Wal-Mart.com USA, LLC